The Association between Serum Vitamin D Level with Breast Cancer and ER/PR, Her-2 in North of Iran

Document Type : Original Article

Authors

1 General physician, student research committee, Babol University of Medical Sciences, Fereydoun Kenar Hospital

2 Pathologist, Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Shahid Beheshti Hospital, Babol

3 Radiotherapist, Cellular and Molecular Biology Research Center, Babol University of Medical Sciences, Shahid Rajaei Hospital, Babolsar

4 Assistant Professor, Biostatistics Department, Shahid Beheshti Hospital, Fertility and Infertility Health Research Center, Babol University of Medical Sciences

5 Senior Nursing Education Expert, Clinical Research Development Unit, Shahid Beheshti Hospital, Babol University of Medical Sciences

6 PhD in Epidemiology, Department of Biostatistics, Faculty of Veterinary Medicine, Amol University of New Technologies

7 Associate Professor of Thoracic Surgery, Babol University of Medical Sciences, Cancer Research Center, Ayatollah Rouhani Hospital, Tehran, Iran

Abstract
Introduction & Objective: Breast cancer is one of the most common cancers in women throughout the world including Iran. There are currently more than 40000 women in Iran suffering from the disease. Studies have shown that the active form of vitamin D, increases cell differentiation and inhibits proliferation, can play a role in changing the risk of breast cancer. Materials & Methods: Present study is analytical and case-control study. In this study150 women with breast cancer and150 women without breast cancer as control were investigated. Including criteria was diagnosis of breast cancer in all cases and absence breast cancer in all control group. Serum vitamin D level, age and marital data included in check list. The obtained data were subjected to chi square, logistic regression and two samples t-test by SPSS software version 23. In all analyses P ˂ 0.05 were as significant difference. Results: Mean level of serum vitamin D in case and control groups were 16.73 ± 11.95 and‌ 27.04 ± 18.49 ng/ml, respectively (‌P < 0.001). Based on multivariable analysis of logistic regression, the risk of developing breast cancer increased with a decrease in serum vitamin D levels. At the level of vitamin deficiency (10 > ng/ml), the odds ratio of illness were 1.93 times higher than the inadequate level. (%95 CI: 0.281; 0.954, P = 0.035), and the odds ratio of getting the disease were 6.9 times higher than the adequate level of vitamin D (%95 CI: 0.075; 0.361, ‌P < 0.001). Also, the serum vitamin D level with estrogen receptors and progesterone receptors was significantly correlated‌ (P‌ < 0.001), but there was no significant correlation with HER-2 receptor ‌(P = 0.195). Conclusions: Based on this study, patients with breast cancer had significantly lower levels of serum vitamin D in comparison with healthy women. Therefore, decreases in serum vitamin D levels are associated with an increased risk of breast cancer.

Keywords


1. Nikbakhsh N, Hashemi S, Lotfabadi R, Siadati S. Types of Pathological Lesions in Breast Cancer in Babol Over 10 Years (2008 – 2017). Journal of Babol University of Medical Sciences. 2017; 19(8): 65-8.
2. Jamshidi Naeeni Y, Davoodi H, Esmaeili S. Effects of Vitamin D on risk of breast cancer. Iranian Journal of Nutrition Sciences & Food Technology. 2013; 7(4): 53-62.
3. Anderson LN, Cotterchio M, Vieth R, Knight JA. Vitamin D and calcium intakes and breast cancer risk in pre-and postmenopausal women. The American journal of clinical nutrition. 2010: ajcn. 28869.
4. Michels KB, Mohllajee AP, Roset-Bahmanyar E, Beehler GP, Moysich KB. Diet and breast cancer. Cancer. 2007; 109(S12): 2712-49.
5. Lee M. M, Lin SS. Dietary fat and breast cancer. Annual review of nutrition. 2000; 20(1): 221-48.
6. Brennan SF, Cantwell MM, Cardwell CR, Velentzis LS, Woodside JV. Dietary patterns and breast cancer risk: a systematic review and meta-analysis. The American journal of clinical nutrition. 2010; 91(5): 1294-302.
7. Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecologic oncology. 2009; 114(1): 121-7.
8. Köstner K, Denzer N, Mueller CS, Klein R, Tilgen W, Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer research. 2009; 29(9):
3511-36.
9. Zhang K, Song L. Association between vitamin D receptor gene polymorphisms and breast cancer risk: a meta-analysis of 39 studies. PLoS One. 2014; 9(4): e96125.
10.    Imtiaz S, Siddiqui N, Raza SA, Loya A, Muhammad A. Vitamin D deficiency in newly diagnosed breast cancer patients. Indian journal of endocrinology and metabolism. 2012; 16(3): 409.
11.    Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, et al. Vitamin D receptor gene polymorphism (s) and breast cancer risk in north Indians. Cancer detection and prevention. 2009; 32(5): 386-94.
12.    Welsh J. Vitamin D and prevention of breast cancer. Acta Pharmacologica Sinica. 2007; 28(9): 1373-82.
13.    Abbas S, Chang-Claude J, Linseisen J. Plasma
25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. International journal of cancer. 2009; 124(1): 250-5.
14.    Campbell MJ, Gombart AF, Kwok SH, Park S, Koeffler HP. The anti-proliferative effects of 1 [alpha], 25 (OH) 2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Oncogene. 2000; 19(44): 5091.
15.    Kawase T, Matsuo K, Suzuki T, Hirose K, Hosono S, Watanabe M, et al. Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan. Cancer science. 2010; 101(5): 1234-40.
16.    Zimmerman BT. Understanding breast cancer genetics: Univ. Press of Mississippi; 2004.